Frequency and clinical correlations of epidermal growth factor receptor (EGFR) mutations in a large cohort of Italian non-small cell lung cancer (NSCLC) patients (pts) within the EGFR FASTnet program.

Nicola Normanno,Carmine Pinto,Gian Luigi Taddei,Giancarlo Troncone,Paolo Graziano,Giovanna De Maglio,Marcella Mottolese,Vienna Ludovini,Simonetta Zupo,Luigi Maria Larocca,Elena Roz,Antonio Russo,Giuseppe Palmieri,Giuseppe Perrone,Massimo Di Maio,Andrea Ardizzoni,Lucio Crino,Francesco Perrone,Claudio Clemente,Antonio Marchetti

Frequency and clinical correlations of epidermal growth factor receptor (EGFR) mutations in a large cohort of Italian non-small cell lung cancer (NSCLC) patients (pts) within the EGFR FASTnet program.

2012

e18021 Background: Gefitinib was approved in Italy for treatment of pts with advanced NSCLC carrying mutant EGFR in May 2010. Methods: The EGFR FASTnet program was designed to facilitate the exchan...

Keywords:

non-small cell lung cancer (NSCLC)
Cohort
Epidermal growth factor receptor
Cancer research
Biology
large cohort
egfr mutation
Oncology
Medicine
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations